Evidence Level
Apple Cider Vinegar (ACV) has been studied for its potential health benefits, particularly in glucose metabolism and weight management. Research by Johnston et al. (2004) demonstrated that vinegar can improve insulin sensitivity after a high-carbohydrate meal, likely through mechanisms such as delayed gastric emptying. This effect was further supported by a systematic review and meta-analysis by Tehrani et al. (2025), which found significant reductions in fasting blood glucose (-21.20 mg/dl) and HbA1c (-0.91%) among adults consuming ACV.
In terms of weight management, Kondo et al. (2009) reported that vinegar intake led to reductions in body weight, fat mass, and triglycerides in obese Japanese subjects. This finding was corroborated by a systematic review and meta-analysis by Castagna et al. (2025), which analyzed 10 RCTs and found that daily ACV consumption significantly reduced body weight, BMI, and waist circumference in overweight or diabetic adults.
However, the evidence for other health claims, such as digestive benefits or improvements in atopic dermatitis, remains limited. A systematic review by Weber et al. (2023) found weak evidence for nutritional supplements, including ACV, in alleviating symptoms of atopic dermatitis. Additionally, ACV gummies typically contain negligible acetic acid and are largely ineffective compared to liquid forms diluted in water.
In summary, while Apple Cider Vinegar shows modest promise in managing blood glucose levels and supporting weight management, its broader health benefits remain unsubstantiated by robust clinical evidence.